General info
Contacts
Monitoring
Monitoring Service — BETA Version
The business change monitoring feature is provided as part of beta testing until 31 August 2026 (inclusive).
The service may be limited and contain inaccuracies.
We do not guarantee data completeness or timeliness and accept no liability for monitoring results.
The service is provided "as is."
Available sectors for monitoring:
Activities
Addresses
Annual report submissions
Business names
Contacts
Employees
Legal Form
Managers
Registration codes
Share Capital
Shareholders
Special Representation Rights
Standard Representation Rights
Statuses
Annual report submissions
Log in or create an account to view this information.
Paid taxes
Log in or create an account to view exact figures.
Employees
Log in or create an account to view exact figures.
Managers
| Role | Name | Code / Date of birth | Residence / location | Start date | Revision date |
|---|---|---|---|---|---|
| Chairman | ANDERS O. | 30374** | ******************** | ********** | |
| Administrative director | JENS K. | 40075***** | ******* | ********** | |
| Director | MARTIN R. | 40041***** | ******* | ********** | |
| Director | MANDANA H. | 40075***** | ******* | ********** | |
| Director | ANNETTE E. | 40075***** | ******* | ********** | |
| Member of the management board | MARTIN R. | 40041***** | ******* | ********** | |
| Member of the management board | MANDANA H. | 40075***** | ******* | ********** | |
| Member of the management board | ANNETTE E. | 40075***** | ******* | ********** | |
| Member of the management board | JENS K. | 40075***** | ******* | ********** |
Log in or create an account to view full information.
Summary
- CELL TO CURE APS has been registered on 07.03.2018.
- The number of active managers in CELL TO CURE APS is 9.
- The number of active shareholders in CELL TO CURE APS is 5.
- The company has been operating in the market for 8 years and 4 months.
- The status of the company is Active.
- The company's activity is NACE Rev.2 - Research and experimental development on biotechnology.
- Share capital is 120 288.00 DKK.
Useful Information
Info about CELL TO CURE APS in other languages
Order report forCELL TO CURE APS
Start monitoring for CELL TO CURE APS
